Protalix BioTherapeutics, Inc. Public Float
Protalix BioTherapeutics, Inc. (PLX) had Public Float of $113.10 million as of 2025-06-30, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-18
- 2025-06-30: Entity Public Float $113.10M.
- 2024-06-30: Entity Public Float $82.00M.
- 2023-06-30: Entity Public Float $139.30M.
- 2022-06-30: Entity Public Float $52.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $113.10M 10-K · filed 2026-03-18 |
| 2024-06-30 | $82.00M 10-K · filed 2025-03-17 |
| 2023-06-30 | $139.30M 10-K · filed 2024-03-14 |
| 2022-06-30 | $52.20M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $85.10M 10-K · filed 2022-03-31 |
| 2020-06-30 | $121.40M 10-K/A · filed 2021-04-30 |
| 2019-06-30 | $68.10M 10-K · filed 2020-03-12 |
| 2018-06-30 | $62.20M 10-K · filed 2019-03-18 |
| 2017-06-30 | $105.40M 10-K · filed 2018-03-06 |
| 2016-06-30 | $61.70M 10-K · filed 2017-03-16 |
| 2015-06-30 | $115.00M 10-K · filed 2016-03-08 |
| 2014-06-30 | $179.00M 10-K · filed 2015-03-12 |
| 2013-06-28 | $286.00M 10-K · filed 2014-03-13 |
| 2012-06-29 | $359.00M 10-K · filed 2013-02-28 |
| 2011-06-30 | $365.00M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |